Jane Street’s Oragenics OGEN Stock Holding History

Jane Street’s Portfolio OGEN Stock Details OGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-32	Closed	-$13K	–	9825
2022 Q3	$13K	Buy	32 +12	+60%	+$7.01K	﹤0.01%	9293
2022 Q2	$12K	Sell	20 -8	-29%	-$4.62K	﹤0.01%	9279
2022 Q1	$17K	Buy	28 +9	+47%	+$6.6K	﹤0.01%	9978
2021 Q4	$15K	Sell	19 -12	-39%	-$12.1K	﹤0.01%	9851
2021 Q3	$35K	Buy	+31	New	+$37.4K	﹤0.01%	9643
2021 Q2	–	Sell	-18	Closed	-$30K	–	10215
2021 Q1	$30K	Buy	+18	New	+$32.7K	﹤0.01%	8931

Other funds holding OGEN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SBF

Sara-Bay Financial Sarasota, Florida $375M AUM 56.53% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Jane Street's OGEN Position: Q4 2022 in Review

Jane Street sold out of Oragenics (OGEN) in Q4 2022, closing a stake of 32 shares — an estimated $13K sold.

Jane Street first reported a position in OGEN in Q1 2021 and held it in 6 quarters. The position peaked at $35K in Q3 2021. 24 funds tracked by Wall St. Rank hold OGEN as of Q4 2022.

Jane Street reported no remaining Oragenics position as of Q4 2022 after selling out during the quarter.
Jane Street sold 32 Oragenics shares in Q4 2022, an estimated $13K.
Jane Street first reported a position in Oragenics in Q1 2021 and held it in 6 quarters.
Jane Street's Oragenics position peaked at $35K in Q3 2021.
24 funds tracked by Wall St. Rank held Oragenics as of Q4 2022.

Based on Jane Street's 13F filing for Q4 2022, filed 15 Feb 2023.